Accordingly, DATS may inhibit tumour cell growth by increasing the expression of Bax in HepG2 cells whilst inhibiting the Bcl-2 expression, thereby inducing apoptosis and killing tumour cells. This evidence concerns the gene BAX and neoplasm.